Engage and Network with 500+ Experts Pioneering the Gene Therapy Field
The therapeutic reality of gene therapies has been seen with recent approvals, but for this early success to be continued, lessons and key insights from the companies who are directly involved in innovative development work must be shared and disseminated.
Established now as the industry-leading event for companies developing gene therapies in the rare disease space, Gene Therapy for Rare Disorders is back in-person, providing an unparalleled opportunity to engage in meaningful discussion with 500+ experts at the forefront of this field. 200+ organizations joined us last time, including:
‘This is one of the best meetings I have ever attended. It was a crash course in everything AAV from manufacturing through clinical applications and commercialization. The quality of the speakers was top notch. The networking was very efficient, and the organization was impeccable.’
Immunospot - 2022 Attendee